# Study of VF001-DP in Patients With Chronic Venous Leg Ulcers

> **NCT02973893** · PHASE2 · UNKNOWN · sponsor: **Factor Therapeutics Ltd.** · enrollment: 156 (estimated)

## Conditions studied

- Ulcer
- Leg Ulcer
- Varicose Ulcer
- Pathologic Processes
- Skin Ulcer
- Skin Diseases
- Vascular Diseases
- Cardiovascular Diseases

## Interventions

- **BIOLOGICAL:** Placebo
- **BIOLOGICAL:** VF001-DP LD
- **BIOLOGICAL:** VF001-DP HD

## Key facts

- **NCT ID:** NCT02973893
- **Lead sponsor:** Factor Therapeutics Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-11
- **Primary completion:** 2018-11
- **Final completion:** 2019-02
- **Target enrollment:** 156 (ESTIMATED)
- **Last updated:** 2018-09-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02973893

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02973893, "Study of VF001-DP in Patients With Chronic Venous Leg Ulcers". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02973893. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
